Skip to main content
Top
Published in: AIDS and Behavior 5/2011

01-07-2011 | Original Paper

Crossing Over: Drug Network Characteristics and Injection Risk Along the China–Myanmar Border

Authors: Chyvette T. Williams, Wei Liu, Judith A. Levy

Published in: AIDS and Behavior | Issue 5/2011

Login to get access

Abstract

Border areas are important locations for understanding HIV transmission. This study examines individual and network correlates of border crossing and equipment sharing among methadone maintenance clients in Ruili City, a Chinese city on the Myanmar border. Data are from 298 clients enrolled in the Ruili Methadone Treatment Center. Clients were interviewed about drug use, HIV/AIDS knowledge, treatment motivation, and their social networks. Multinomial and logistic regression analysis were performed. Thirty percent of clients reported injecting in Myanmar. Compared to drug networks that usually inject in China, networks that inject equally in both places (border crossing) are more likely to share equipment. The association between HIV positive status and border-crossing was marginally significant and robust. Results indicate some added degree of risk among clients and drug networks who border-cross to use drugs. More research is needed to understand this phenomenon.
Literature
1.
go back to reference UNAIDS. AIDS Epidemic Update 2009: Asia fact sheet. Geneva: Joint United Nations Programme on HIV/AIDS; 2009. UNAIDS. AIDS Epidemic Update 2009: Asia fact sheet. Geneva: Joint United Nations Programme on HIV/AIDS; 2009.
2.
go back to reference Beyrer C, Razak MH, Lisam K, Chen J, Lui W, Yu XF. Overland heroin trafficking routes and HIV-1 spread in South and South-East Asia. AIDS. 2000;14(1):75–83.PubMedCrossRef Beyrer C, Razak MH, Lisam K, Chen J, Lui W, Yu XF. Overland heroin trafficking routes and HIV-1 spread in South and South-East Asia. AIDS. 2000;14(1):75–83.PubMedCrossRef
3.
go back to reference Beyrer C. HIV/AIDS: HIV epidemiology update and transmission factors: Risks and risk contexts—16th international AIDS conference epidemiology plenary. Clin Infect Dis. 2007;44(7):981–7.PubMedCrossRef Beyrer C. HIV/AIDS: HIV epidemiology update and transmission factors: Risks and risk contexts—16th international AIDS conference epidemiology plenary. Clin Infect Dis. 2007;44(7):981–7.PubMedCrossRef
4.
go back to reference UNESCO. HIV/AIDS in the GMS: a cross-border problem. Bulletin for prevention education in the greater Mekong subregion, Issue 1, 1–3. Thailand: HIV/AIDS Clearing House of the UNESCO Asia and Pacific Regional Bureau for Education; 2004. UNESCO. HIV/AIDS in the GMS: a cross-border problem. Bulletin for prevention education in the greater Mekong subregion, Issue 1, 1–3. Thailand: HIV/AIDS Clearing House of the UNESCO Asia and Pacific Regional Bureau for Education; 2004.
5.
go back to reference du Guerny J, Hsu L-N, Hong C. Population movement and HIV/AIDS: the case of Ruili, Yunnan, China. UNDP Southeast Asia HIV and Development Programme; August 2003 du Guerny J, Hsu L-N, Hong C. Population movement and HIV/AIDS: the case of Ruili, Yunnan, China. UNDP Southeast Asia HIV and Development Programme; August 2003
6.
go back to reference Strathdee SA, Lozada R, Ojeda VD, Pollini RA, Brouwer KC, Vera A, et al. Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PLoS One. 2008;3(7):e2690.PubMedCrossRef Strathdee SA, Lozada R, Ojeda VD, Pollini RA, Brouwer KC, Vera A, et al. Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PLoS One. 2008;3(7):e2690.PubMedCrossRef
7.
go back to reference Beesey A. HIV vulnerability and mobile populations: Thailand and its borders. Dev Bull. 2000;52(52):38–41.PubMed Beesey A. HIV vulnerability and mobile populations: Thailand and its borders. Dev Bull. 2000;52(52):38–41.PubMed
8.
go back to reference Zhao C, Liu Z, Zhao D, Liu Y, Liang J, Tang Y, et al. Drug abuse in China. Ann N Y Acad Sci. 2004;1025:439–45.PubMedCrossRef Zhao C, Liu Z, Zhao D, Liu Y, Liang J, Tang Y, et al. Drug abuse in China. Ann N Y Acad Sci. 2004;1025:439–45.PubMedCrossRef
9.
go back to reference Zheng X, Tian C, Choi K-H, et al. Injecting drug use and HIV infection in southwest China. AIDS. 1994;8:1141–7.PubMedCrossRef Zheng X, Tian C, Choi K-H, et al. Injecting drug use and HIV infection in southwest China. AIDS. 1994;8:1141–7.PubMedCrossRef
10.
go back to reference Xia M, Kreiss JK, Holmes KK. Risk factors for HIV infection among drug users in Yunnan province, China: association with intravenous drug use and protective effect of boiling reusable needles and syringes. AIDS. 1994;8:1701–6.PubMedCrossRef Xia M, Kreiss JK, Holmes KK. Risk factors for HIV infection among drug users in Yunnan province, China: association with intravenous drug use and protective effect of boiling reusable needles and syringes. AIDS. 1994;8:1701–6.PubMedCrossRef
11.
go back to reference Yu ESH, Xie Q, Zhang K, et al. HIV infection and AIDS in China, 1985 through 1994. Am J Public Health. 1996;86:1116–22.PubMedCrossRef Yu ESH, Xie Q, Zhang K, et al. HIV infection and AIDS in China, 1985 through 1994. Am J Public Health. 1996;86:1116–22.PubMedCrossRef
12.
go back to reference Ministry of Health, P. R. China and UN Theme Group on HIV/AIDS in China. China responds to AIDS: HIV/AIDS situation and needs assessment report. Beijing: Chinese Ministry of Health, November 1997. Ministry of Health, P. R. China and UN Theme Group on HIV/AIDS in China. China responds to AIDS: HIV/AIDS situation and needs assessment report. Beijing: Chinese Ministry of Health, November 1997.
13.
go back to reference Zheng X, Tian C, Choi KH, Zhang J, Cheng H, Yang X, et al. Injecting drug use and HIV infection in Southwest China. AIDS. 1994;8(8):1141–7.PubMedCrossRef Zheng X, Tian C, Choi KH, Zhang J, Cheng H, Yang X, et al. Injecting drug use and HIV infection in Southwest China. AIDS. 1994;8(8):1141–7.PubMedCrossRef
14.
go back to reference Chu TX, Levy JA. Injection drug use and HIV/AIDS transmission in China. Cell Res. 2005;15(11–12):865–9.PubMedCrossRef Chu TX, Levy JA. Injection drug use and HIV/AIDS transmission in China. Cell Res. 2005;15(11–12):865–9.PubMedCrossRef
15.
go back to reference Chantavanich S. Preventing HIV/AIDS among mobile populations in the greater Mekong subregion, Asian Development Bank, the United Nations Development Program; 2000. Chantavanich S. Preventing HIV/AIDS among mobile populations in the greater Mekong subregion, Asian Development Bank, the United Nations Development Program; 2000.
16.
go back to reference Zheng XW, Zhang JP, Tian CQ, Cheng HH, Yang XZ, Duan S, et al. Cohort study of HIV infection among drug users in Ruili, Longchuan and Luxi of Yunnan Province, China. Biomed Environ Sci. 1993;6(4):348–51.PubMed Zheng XW, Zhang JP, Tian CQ, Cheng HH, Yang XZ, Duan S, et al. Cohort study of HIV infection among drug users in Ruili, Longchuan and Luxi of Yunnan Province, China. Biomed Environ Sci. 1993;6(4):348–51.PubMed
17.
go back to reference Yu XF, Chen J, Shao Y, Beyrer C, Liu B, Wang Z, et al. Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. J Acquir Immune Defic Syndr. 1999;22(2):180–8.PubMedCrossRef Yu XF, Chen J, Shao Y, Beyrer C, Liu B, Wang Z, et al. Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. J Acquir Immune Defic Syndr. 1999;22(2):180–8.PubMedCrossRef
18.
go back to reference Xiao Y, Kristensen S, Sun J, Lu L, Vermund SH. Expansion of HIV/AIDS in China: lessons from Yunnan Province. Soc Sci Med. 2007;64(3):665–75.PubMedCrossRef Xiao Y, Kristensen S, Sun J, Lu L, Vermund SH. Expansion of HIV/AIDS in China: lessons from Yunnan Province. Soc Sci Med. 2007;64(3):665–75.PubMedCrossRef
19.
go back to reference Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R. Evolution of China’s response to HIV/AIDS. Lancet. 2007;369(9562):679–90.PubMedCrossRef Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R. Evolution of China’s response to HIV/AIDS. Lancet. 2007;369(9562):679–90.PubMedCrossRef
20.
go back to reference Des Jarlais DC, Johnston P, Friedmann P, Kling R, Liu W, Ngu D, et al. Patterns of HIV prevalence among injecting drug users in the cross-border area of Lang Son Province, Vietnam, and Ning Ming County, Guangxi Province, China. BMC Public Health. 2005;5:89.PubMedCrossRef Des Jarlais DC, Johnston P, Friedmann P, Kling R, Liu W, Ngu D, et al. Patterns of HIV prevalence among injecting drug users in the cross-border area of Lang Son Province, Vietnam, and Ning Ming County, Guangxi Province, China. BMC Public Health. 2005;5:89.PubMedCrossRef
21.
go back to reference Hammett TM, Johnston P, Kling R, Liu W, Ngu D, Tung ND, et al. Correlates of HIV status among injection drug users in a border region of Southern China and Northern Vietnam. J Acquir Immune Defic Syndr. 2005;38(2):228–35.PubMedCrossRef Hammett TM, Johnston P, Kling R, Liu W, Ngu D, Tung ND, et al. Correlates of HIV status among injection drug users in a border region of Southern China and Northern Vietnam. J Acquir Immune Defic Syndr. 2005;38(2):228–35.PubMedCrossRef
22.
go back to reference Hammett TM, Kling R, Johnston P, Liu W, Ngu D, Friedmann P, et al. Patterns of HIV prevalence and HIV risk behaviors among injection drug users prior to and 24 months following implementation of cross-border HIV prevention interventions in northern Vietnam and southern China. AIDS Educ Prev. 2006;18(2):97–115.PubMedCrossRef Hammett TM, Kling R, Johnston P, Liu W, Ngu D, Friedmann P, et al. Patterns of HIV prevalence and HIV risk behaviors among injection drug users prior to and 24 months following implementation of cross-border HIV prevention interventions in northern Vietnam and southern China. AIDS Educ Prev. 2006;18(2):97–115.PubMedCrossRef
23.
go back to reference Bergenstrom A, Htoon YS, Sharma M, Garg R, Macdonald V, Awng H, Buhler M, Gang S. Myanmar country advocacy brief injecting drug use and HIV. A joint publication by United Nations Regional Task Force on injecting drug use and HIV/AIDS for Asia and the Pacific and HIV/AIDS Asia Regional Program, 2010. Bergenstrom A, Htoon YS, Sharma M, Garg R, Macdonald V, Awng H, Buhler M, Gang S. Myanmar country advocacy brief injecting drug use and HIV. A joint publication by United Nations Regional Task Force on injecting drug use and HIV/AIDS for Asia and the Pacific and HIV/AIDS Asia Regional Program, 2010.
24.
go back to reference De P, Cox J, Boivin J-F, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction. 2007;102(11):1730–9.PubMedCrossRef De P, Cox J, Boivin J-F, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction. 2007;102(11):1730–9.PubMedCrossRef
25.
go back to reference Williams CT, Latkin CA. Neighborhood socio-economic status, personal networks, and adult heroin and cocaine use. Am J Prev Med. 2007;32(6S):S203–10.PubMedCrossRef Williams CT, Latkin CA. Neighborhood socio-economic status, personal networks, and adult heroin and cocaine use. Am J Prev Med. 2007;32(6S):S203–10.PubMedCrossRef
26.
go back to reference Williams CT, Metzger D. Race and distance effects on regular syringe exchange program use and other injection risks: a geo-behavioral analysis. Am J Public Health. (in press) Williams CT, Metzger D. Race and distance effects on regular syringe exchange program use and other injection risks: a geo-behavioral analysis. Am J Public Health. (in press)
27.
go back to reference Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:273–80.PubMedCrossRef Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:273–80.PubMedCrossRef
28.
go back to reference Rothenberg RB, Potterat JJ, Woodhouse DE, Muth SQ, Darrow WW, Klovdahl AS. Social network dynamics and HIV transmission. AIDS. 1998;12:1529–36.PubMedCrossRef Rothenberg RB, Potterat JJ, Woodhouse DE, Muth SQ, Darrow WW, Klovdahl AS. Social network dynamics and HIV transmission. AIDS. 1998;12:1529–36.PubMedCrossRef
29.
go back to reference Loftus E, Smith K, Klinger M, Fiedler J. Memory and mismemory for health events. In: Tanur JM, editor. Questions about questions: Inquiries into the cognitive bases of surveys. New York: Russell Sage Foundation; 1991. p. 102–37. Loftus E, Smith K, Klinger M, Fiedler J. Memory and mismemory for health events. In: Tanur JM, editor. Questions about questions: Inquiries into the cognitive bases of surveys. New York: Russell Sage Foundation; 1991. p. 102–37.
Metadata
Title
Crossing Over: Drug Network Characteristics and Injection Risk Along the China–Myanmar Border
Authors
Chyvette T. Williams
Wei Liu
Judith A. Levy
Publication date
01-07-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9764-2

Other articles of this Issue 5/2011

AIDS and Behavior 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.